Cancer

Accelerating cancer from detection to discovery​

Cancer affects millions worldwide, but insightful discoveries in cancer genomics have revealed that tumors are not single diseases but complex ecosystems of genetic variants, cellular heterogeneity, and dynamic biomarker profiles. Understanding these molecular landscapes is critical for developing precision therapies, identifying resistance mechanisms, and improving molecular subtyping.​

Revvity's integrated cancer research platform enables scientists to decode tumor biology at multiple levels — from single-cell resolution to population-wide screening —generating the high-quality data needed for reproducible discoveries and translational success.​

​Early detection & screening

• HPV Testing — Enable population-level cervical cancer prevention through accurate viral detection​
• Flow Cytometry Solutions — Characterize immune cell populations and tumor microenvironments with precision​

Genomic profiling & molecular analysis​

• Cancer Genomics — Map somatic mutations, copy number variations, and structural rearrangements​
• Targeted Sequencing — Focus sequencing power on actionable mutations and clinical biomarkers​
• Single Cell Sequencing — Resolve intratumoral heterogeneity and identify rare cell populations driving metastasis​

​Liquid biopsy & circulating biomarkers

• miRNA Analysis — Test regulatory RNA signatures for research on early-stage cancer identification​
• Exosome & cfRNA Analysis — Capture tumor-derived signals in blood for non-invasive monitoring​
• Biomarker Discovery — Identify novel prognostic and predictive markers for clinical translation​

Functional validation & reproducibility​

• Functional Testing — Validate pathway activity and drug mechanism of action​
• Mimix™ Reference Standards — Verify and monitor workflows with confidence​

Accelerate your path from discovery to clinical impact with solutions designed for cancer science.